Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
GRCE.OQ - Grace Therapeutics, Inc
Grace Therapeutics, Inc at TD Cowen Healthcare Conference
Mar 04, 2026 / 03:30PM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Well, thanks to everyone for joining our forty-sixth annual healthcare conference. I'm Stacy Ku, part of the biotech team with my colleague Vish Shaw, and we'd like to welcome Prashant Kohli, CEO of Grace Therapeutics. So, very exciting times for the company as Grace is fast approaching the April 23rd PUA date for GTX 104 and the treatment of aneurysm. Subarachnoid hemorrhage, which we'll refer to as ASAH, for short, from now on, I'm sure the company is very much focused on the preparation ahead of commercialization.
But before we dig into the launch, maybe very quickly, could you provide some background on GTX 104, and really, have that interplayed with the current standard of care to currently treat
Trustpilot
